Finance

Lists
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
7,30 US$
+0,27%
(+0,020) 1D
7,35 US$
+0,70% (+0,051)
After hours
Closed: 9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNXP...
Open
7,27 US$
High
7,54 US$
Low
7,09 US$
Mkt. cap
125,20 მლნ.
Avg. vol.
580,80 ათ.
Volume
963,56 ათ.
52-wk high
22,38 US$
52-wk low
7,09 US$
EPS
-12,92 US$
Beta
1,78
Shares outstanding
17,15 მლნ.
No. of employees
142
Open
7,27 US$
High
7,54 US$
Low
7,09 US$
Mkt. cap
125,20 მლნ.
Avg. vol.
580,80 ათ.
Volume
963,56 ათ.
52-wk high
22,38 US$
52-wk low
7,09 US$
EPS
-12,92 US$
Beta
1,78
Shares outstanding
17,15 მლნ.
No. of employees
142
News stories
From web sources and news partners
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOსეთ ლედერმანი
Employees142
Founded2007
HeadquartersBerkeley Heights, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to TNXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TNXP in the last 3 months.
Highest
Current 7,30 US$
65,00 US$ (+790,41%)
Average
38,00 US$ (+420,55%)
Lowest
22,00 US$ (+201,37%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Molloy
Alliance Global Partners
Buy
Reiterated
65,00 US$
+790,4%
09/28/2026
Stacy Ku
TD Cowen
Buy
Maintained
22,00 US$
+201,4%
08/10/2026
Tiago Fauth
Raymond James
Buy
Reiterated
27,00 US$
+269,9%
08/10/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
37,00 US$
+406,8%
03/16/2026
Last report
10 აგვ. 2026
Fiscal period
Q2 2026
-2,47 US$ / -2,62 US$
+5,58%beat
Revenue / Est. (USD)
13,54 მლნ. / 7,72 მლნ.
+75,38%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,29 მლნ.
5,39 მლნ.
6,88 მლნ.
13,54 მლნ.
Cost of goods sold
1,37 მლნ.
1,06 მლნ.
1,58 მლნ.
703,00 ათ.
Cost of revenue
1,37 მლნ.
1,06 მლნ.
1,58 მლნ.
703,00 ათ.
Research and development expenses
9,29 მლნ.
16,94 მლნ.
18,21 მლნ.
19,42 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,70 მლნ.
35,68 მლნ.
28,62 მლნ.
35,96 მლნ.
Operating expense
34,99 მლნ.
52,62 მლნ.
46,84 მლნ.
55,38 მლნ.
Total operating expenses
36,36 მლნ.
53,68 მლნ.
48,42 მლნ.
56,08 მლნ.
Operating income
-33,07 მლნ.
-48,29 მლნ.
-41,54 მლნ.
-42,54 მლნ.
Other non operating income
-174,00 ათ.
32,00 ათ.
-3,00 ათ.
551,00 ათ.
EBT including unusual items
-32,01 მლნ.
-46,91 მლნ.
-40,19 მლნ.
-40,55 მლნ.
EBT excluding unusual items
-32,01 მლნ.
-46,91 მლნ.
-40,19 მლნ.
-40,55 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-32,01 მლნ.
-46,91 მლნ.
-40,19 მლნ.
-40,55 მლნ.
Net profit margin
-972,95%
-870,32%
-584,38%
-299,41%
Earnings per share
-3,70
-3,98
-2,93
-2,47
Interest and investment income
1,23 მლნ.
1,34 მლნ.
1,35 მლნ.
1,43 მლნ.
Interest expense
-
-
-
-
Net interest expenses
1,23 მლნ.
1,34 მლნ.
1,35 მლნ.
1,43 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-32,61 მლნ.
-47,80 მლნ.
-40,98 მლნ.
-41,92 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები